Safety and Efficacy of Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation

被引:0
|
作者
Waghray, Abhijeet [1 ]
Balci, Bengi [1 ]
El-Gazzaz, Galal [1 ]
Miller, Charles M. [1 ]
Pelley, Robert J. [1 ]
Aucejo, Federico N. [1 ]
Menon, K. V. Narayanan [2 ]
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
559
引用
收藏
页码:463A / 464A
页数:2
相关论文
共 50 条
  • [1] Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
    Waghray, Abhijeet
    Balci, Bengi
    El-Gazzaz, Galal
    Kim, Richard
    Pelley, Robert
    Menon, K. V. Narayanan
    Estfan, Bassam
    Romero-Marrero, Carlos
    Aucejo, Federico
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : 555 - 561
  • [2] Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?
    Vitale, A.
    Boccagni, P.
    Kertusha, X.
    Zanus, G.
    D'Amico, F.
    Lodo, E.
    Pastorelli, D.
    Morales, R. Ramirez
    Lombardi, G.
    Senzolo, M.
    Burra, P.
    Cillo, U.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (07) : 1989 - 1991
  • [3] Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Sotiropoulos, G. C.
    Nowak, K. W.
    Fouzas, I.
    Vernadakis, S.
    Kykalos, S.
    Klein, C. G.
    Paul, A.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2754 - 2756
  • [4] Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
    Yoon, Dok Hyun
    Ryoo, Baek-Yeol
    Ryu, Min-Hee
    Lee, Sung-Gyu
    Hwang, Shin
    Suh, Dong Jin
    Lee, Han Chu
    Kim, Tae Won
    Ahn, Chul-Soo
    Kim, Ki-Hun
    Moon, Deok-Bog
    Kang, Yoon-Koo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (08) : 768 - 773
  • [5] Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
    Kim, Bo Hyun
    Park, Joong-Won
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (45)
  • [6] Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
    Zhang, Xia
    Cai, Lirong
    Fang, Jian
    Chen, Fengsui
    Pan, Fan
    Zhang, Kun
    Huang, Qian
    Huang, Yuju
    Li, Dongliang
    Lv, Lizhi
    Chen, Man
    Yan, Ruiying
    Lai, Yanhua
    Peng, Yonghai
    Wu, Zhixian
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [7] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival
    Mazza, S.
    Invernizzi, F.
    Iavarone, M.
    Zavaglia, C.
    Maggi, U.
    Cesarini, L.
    Antonelli, B.
    Airoldi, A.
    Manini, M. A.
    Sangiovanni, A.
    Rossi, G.
    Donato, M. F.
    Belli, L. S.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E35 - E35
  • [8] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
    Invernizzi, F.
    Iavarone, M.
    Donato, M. F.
    Sangiovanni, A.
    Monico, S.
    Manini, M. A.
    Maggi, U.
    Antonelli, B.
    Dondossola, D.
    Rossi, G.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 49 - 49
  • [9] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
    Invernizzi, Federica
    Iavarone, Massimo
    Zavaglia, Claudio
    Mazza, Stefano
    Maggi, Umberto
    Cesarini, Lucia
    Antonelli, Barbara
    Airoldi, Aldo
    Manini, Matteo Angelo
    Sangiovanni, Angelo
    Rossi, Giorgio
    Donato, Maria Francesca
    Belli, Luca Saverio
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E560 - E561
  • [10] Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
    Gomez-Martin, Carlos
    Bustamante, Javier
    Castroagudin, Javier F.
    Salcedo, Magdalena
    Garralda, Elena
    Testillano, Milagros
    Herrero, Ignacio
    Matilla, Ana
    Sangro, Bruno
    LIVER TRANSPLANTATION, 2012, 18 (01) : 45 - 52